49
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
527733
MultiVir is a clinical-stage gene therapy company
- Robert E. Sobol: CEO & Founder
About the Company
MultiVir, Inc., a clinical-stage gene therapy company, engages in developing a pipeline of product candidates for the treatment of various oncological indications. The company’s lead product candidates that has completed Phase 1 clinical trials include Ad-p53, a genetically modified adenovirus designed to deliver the normal p53 tumor suppressor
gene, which targets fundamental molecular defects present in various types of cancers; and Ad-IL24, a genetically engineered adenovirus modified to deliver the tumor suppressor gene interleukin-24 that has tumor suppressor activities similar to p53 and certain immunostimulatory properties.
